InVivo Therapeutics Corp Kurs/ Buchwert
Was ist das Kurs/ Buchwert von InVivo Therapeutics Corp?
Kurs/ Buchwert von InVivo Therapeutics Holdings Corp ist 0.22
Was ist die Definition von Kurs/ Buchwert?
Kurs-Buchwert-Verhältnis repräsentiert das Verhältnis zwischen dem Aktienwert eines Unternehmens und dem Buchwert pro Aktie.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Kurs/ Buchwert von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu InVivo Therapeutics Corp
Was macht InVivo Therapeutics Corp?
about invivo therapeutics invivo therapeutics holdings corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. the company was founded in 2005 with proprietary technology co-invented by robert langer, sc.d., professor at massachusetts institute of technology, and joseph p. vacanti, m.d., who then was at boston children’s hospital and who now is affiliated with massachusetts general hospital. in 2011, the company earned the david s. apple award from the american spinal injury association for its outstanding contribution to spinal cord injury medicine. in 2015, the company’s investigational neuro-spinal scaffold received the 2015 becker’s healthcare spine device award. the publicly-traded company is headquartered in cambridge, ma. for more details, visit www.invivotherapeutics.com. about the neuro-spinal scaffold™ following acute spinal cord injury, surgical implantation of the biodegradable neuro-spinal scaffold wi
Unternehmen mit kurs/ buchwert ähnlich InVivo Therapeutics Corp
- Sierra Metals hat Kurs/ Buchwert von 0.22
- Thor Mining Plc hat Kurs/ Buchwert von 0.22
- Amazon.com hat Kurs/ Buchwert von 0.22
- Voyager Digital hat Kurs/ Buchwert von 0.22
- Brand Architekts plc hat Kurs/ Buchwert von 0.22
- Planet Ventures hat Kurs/ Buchwert von 0.22
- InVivo Therapeutics Corp hat Kurs/ Buchwert von 0.22
- TTL Beteiligungs- und Grundbesitz-AG hat Kurs/ Buchwert von 0.22
- Hydoo International hat Kurs/ Buchwert von 0.22
- Tsakos Navigation hat Kurs/ Buchwert von 0.22
- China Communications Construction Co hat Kurs/ Buchwert von 0.22
- China Development Bank International Investment hat Kurs/ Buchwert von 0.22
- Integrated Waste Solutions hat Kurs/ Buchwert von 0.22